Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma

Saved in:
Bibliographic Details
Published inNeurology Vol. 74; no. 16; p. 1330
Main Authors Rosenow, F, Reif, P S, Haag, A, Schmidt, K, Strik, H
Format Journal Article
LanguageEnglish
Published United States 20.04.2010
Subjects
Anticonvulsants - pharmacology
Anticonvulsants - therapeutic use
Antineoplastic Agents - agonists
Antineoplastic Agents - therapeutic use
Brain Neoplasms - drug therapy
Brain Neoplasms - mortality
Brain Neoplasms - pathology
Clinical Trials as Topic - methods
Clinical Trials as Topic - standards
Comorbidity
Data Interpretation, Statistical
Disease Progression
Enzymes - drug effects
Enzymes - metabolism
Epilepsy - drug therapy
Epilepsy - epidemiology
Epilepsy - physiopathology
Glioblastoma - drug therapy
Glioblastoma - mortality
Glioblastoma - pathology
Humans
Incidence
Outcome Assessment (Health Care) - methods
Outcome Assessment (Health Care) - standards
Severity of Illness Index
Survival Rate
Treatment Outcome
Online AccessGet more information

Cover

More Information
ISSN:1526-632X
DOI:10.1212/WNL.0b013e3181d8a5c2